Patents-Review.com
🔗 Permalink
Inventor profile of:

Daniel Olive

City:

Marseilles

Country:

France

Published Applications:

27

Last publication date:

2025-04-24

Top Assignees for applications by Daniel Olive

The entities that hold a legal rights for patent applications filed by inventor Olive Daniel:

Recent patent applications by Olive Daniel

Daniel Olive from Marseilles, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-04-24
US20250127916A1
Human necessities

ANTIBODY DRUG CONJUGATE (ADC) TARGETING NECTIN 4 AND COMPRISING AN EXATECAN PAYLOAD

 #2 | 2024-02-01
US20240034791A1
Chemistry; metallurgy

Anti-nectin-4-antibodies and uses thereof

 #3 | 2023-10-12
US20230322932A1
Chemistry; metallurgy

Anti-BTN3A antibodies and their use in treating cancer or infectious disorders

 #4 | 2023-06-15
US20230183337A1
Chemistry; metallurgy

ANTIBODIES HAVING SPECIFICITY FOR NECTIN-4 AND USES THEREOF

 #5 | 2022-05-26
US20220162305A1
Chemistry; metallurgy

Antibodies having specificity for BTN2 and uses thereof

 #6 | 2022-04-14
US20220112289A1
Chemistry; metallurgy

Anti-BTN3A antibodies and their use in treating cancer or infectious disorders

 #7 | 2022-03-10
US20220073619A1
Chemistry; metallurgy

BTN3A binding proteins and uses thereof

 #8 | 2020-12-03
US20200376104A1
Human necessities

Anti-CD277 antibodies

 #9 | 2020-09-10
US20200283519A1
Chemistry; metallurgy

Antibodies having specificity for BTN2 and uses thereof

 #10 | 2019-11-21
US20190352400A1
Chemistry; metallurgy

Antibodies directed against ICOS and uses thereof

 #11 | 2019-10-17
US20190315866A1
Chemistry; metallurgy

Antibodies directed against ICOS and uses thereof

 #12 | 2019-07-04
US20190201513A1
Human necessities

Anti-CD277 antibodies

 #13 | 2018-08-30
US20180244780A1
Chemistry; metallurgy

Antibodies directed against ICOS and uses thereof

 #14 | 2018-08-30
US20180243434A1
Human necessities

Antibodies having specificity to nectin-4 and uses thereof

 #15 | 2017-09-28
US20170275372A1
Chemistry; metallurgy

Antibodies directed against ICOS for treating graft-versus-host disease

 #16 | 2017-08-17
US20170233478A1
Chemistry; metallurgy

Antibodies directed against ICOS and uses thereof

 #17 | 2016-09-15
US20160264666A1
Chemistry; metallurgy

Antibodies directed against ICOS and uses thereof

 #18 | 2016-03-31
US20160090420A1
Chemistry; metallurgy

Antagonist of the BTLA/HVEM interaction for use in therapy

 #19 | 2015-08-27
US20150239978A1
Chemistry; metallurgy

Antibodies directed against ICOS for treating graft-versus-host disease

 #20 | 2015-05-28
US20150147344A1
Chemistry; metallurgy

BTLA antibodies and uses thereof

 #21 | 2014-11-13
US20140335093A1
Chemistry; metallurgy

PD-1 antibodies and PD-L1 antibodies and uses thereof

 #22 | 2014-06-26
US20140178394A1
Chemistry; metallurgy

Antigen peptide and uses thereof

 #23 | 2014-03-27
US20140086923A1
Chemistry; metallurgy

Antibodies directed against ICOS and uses thereof

 #24 | 2012-02-16
US20120039906A1
Chemistry; metallurgy

PD-1 antibodies and PD-L1 antibodies and uses thereof

 #25 | 2011-07-21
US20110177088A1
Chemistry; metallurgy

Method for treating and diagnosing hematologic malignancies

 #26 | 2010-08-05
US20100196386A1
Chemistry; metallurgy

Ligands of HVEM for treating hematologic malignancies

 #27 | 2008-02-14
US20080038273A1
Chemistry; metallurgy

Anti-CD28 antibody
InventorID:

5996703 ⎘